Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU4ATAC4P** is designated as a pseudogene related to the U4atac small nuclear RNA family. Pseudogenes are genomic sequences similar to known genes but are typically nonfunctional; they do not produce active protein or RNA products and, as such, do not directly participate in biological processes or serve as targets for drugs. The functional RNU4ATAC gene encodes the U4atac small nuclear RNA, an essential component of the minor spliceosome complex involved in the splicing of U12-type introns from pre-mRNAs[3][5]. However, RNU4ATAC4P itself is annotated as a pseudogene and is not known to produce a functional RNA product. It does not play a documented role in human disease, is not regarded as a therapeutic target, and has no known associated drugs, mechanism of action, biomarkers, or safety profile. The information for RNU4ATAC4P is distinct from that describing the functional RNU4ATAC gene. For the study or targeting of spliceosomal function or related diseases, the relevant entity would be the functional RNU4ATAC gene, not its pseudogene[5]. Key points: - **RNU4ATAC4P is a pseudogene and not a molecular target.** - It has no known molecular function, biological roles, or clinical relevance as a target. - Most literature and resources focus on the functional RNU4ATAC gene and its involvement in rare developmental disorders[3][5]. - The entry appears to be largely informational and not relevant for drug targeting, therapeutic intervention, or biomarker development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4atac small nuclear 4, pseudogene (RNU4ATAC4P).